The invention provides compounds represented by the structural formula (1):
wherein R
1
, R
2
, R
3
and R
4
are as defined in the claims. The compounds are inhibitors of nucleases, and are useful in particular in a method of treatment and/or prevention of proliferative diseases, neurodegenerative diseases, and other genomic instability associated diseases.
US9969741B2
申请人:——
公开号:US9969741B2
公开(公告)日:2018-05-15
[EN] PYRAZOLOTRIAZINES AS INHIBITORS OF NUCLEASES<br/>[FR] PYRAZOLOTRIAZINES EN TANT QU'INHIBITEURS DE NUCLÉASES
申请人:UNIV MASARYKOVA
公开号:WO2015192817A1
公开(公告)日:2015-12-23
The invention provides compounds represented by the structural formula (1): wherein R1, R2, R3 and R4 are as defined in the claims. The compounds are inhibitors of nucleases, and are useful in particular in a method of treatment and/or prevention of proliferative diseases, neurodegenerative diseases, and other genomic instability associated diseases. ˙